Sensitivity and specificity of different antibody tests for detecting varicella-zoster virus

J Infect Chemother. 2020 Dec;26(12):1283-1287. doi: 10.1016/j.jiac.2020.07.012. Epub 2020 Aug 22.

Abstract

Introduction: Antibody tests for detecting varicella-zoster virus include the fluorescent-antibody-to-membrane-antigen (FAMA) assay, immune adherence hemagglutination assay (IAHA), enzyme immunoassay (EIA), and the glycoprotein-based enzyme-linked immunosorbent assay (gpELISA). Although FAMA and gpELISA are highly sensitive, FAMA is not available commercially. Therefore, this study was performed to compare potential high-sensitivity tests with commercially available tests.

Methods: Four antibody tests, FAMA, gpELISA, EIA, and IAHA, were performed using sera collected from 32 children aged 7 months-10 years. Using FAMA as a reference, the sensitivity and specificity of gpELISA, EIA, and IAHA were assessed. Subsequently, using gpELISA as a reference, the positive agreement rate of EIA and IAHA was assessed.

Results: On a reference scale with FAMA set at 100%, the sensitivity and specificity of the antibody tests were as follows: gpELISA, 67% and 100%; EIA, 67% and 100%; and IAHA, 47% and 100%, respectively. The positive agreement rates of EIA and IAHA relative to gpELISA were 86% and 64%, respectively.

Conclusions: gpELISA had a lower positive rate than did FAMA, and showed comparable sensitivity to that of EIA.

Keywords: Antibody; EIA; FAMA; Vaccine; Varicella-zoster virus; gpELISA.

MeSH terms

  • Antibodies, Viral
  • Chickenpox*
  • Child
  • Enzyme-Linked Immunosorbent Assay
  • Fluorescent Antibody Technique
  • Herpesvirus 3, Human*
  • Humans
  • Immunoenzyme Techniques
  • Sensitivity and Specificity

Substances

  • Antibodies, Viral